0.5700
-0.0100
(-1.72%)
At close: January 10 at 2:08:32 PM EST
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -0.13 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TTI.V | -- | -- | -- | -- |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Related Tickers
NWRN.SW Newron Pharmaceuticals S.p.A.
8.88
+1.72%
SANN.SW Santhera Pharmaceuticals Holding AG
13.68
-2.84%
RLF.SW Relief Therapeutics Holding SA
3.8500
-1.53%
RKV.V Rakovina Therapeutics Inc.
0.1750
-2.78%
IDIA.SW Idorsia Ltd
0.7790
-1.77%
GBIO Generation Bio Co.
0.9255
+1.69%
BOLT Bolt Biotherapeutics, Inc.
0.5387
-4.69%
SVA.TO Sernova Corp.
0.2250
0.00%
NCNA NuCana plc
1.1300
-1.74%
PBM Psyence Biomedical Ltd.
1.7000
-7.61%